Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 2

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04621279Recruiting

Cool Prime Comparative Effectiveness Study for Mild HIE

Role: collaborator

NCT03624517Phase 4Terminated

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Role: collaborator

NCT02598349Phase 2Recruiting

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Role: collaborator

NCT00969111Not ApplicableRecruiting

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Role: collaborator

NCT05849077Not ApplicableRecruiting

Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)

Role: collaborator

NCT06222385Not ApplicableCompleted

Applied Cognition Benchmarking Study

Role: collaborator

NCT05390775Not ApplicableCompleted

Written Exposure Therapy to Improve Lives After Stress Exposure

Role: collaborator

NCT03534063Not ApplicableCompleted

Implementing Genomics in Practice (IGNITE): CYP2D6 Genotype-Guided Pain Management in Patients Undergoing Arthroplasty Surgery

Role: collaborator

NCT02326675Not ApplicableTerminated

Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant

Role: collaborator

All 9 trials loaded